Immunome
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $2,910 | $2,364 | $1,028 | $3,826 |
Gross Profit | 2,910 | 1,691 | 765 | 3,569 |
EBITDA | -50,522 | -35,449 | -20,188 | -13,700 |
EBIT | -51,093 | -36,122 | -20,451 | -13,957 |
Net Income | -47,100 | -36,122 | -129,491 | -92,634 |
Net Change In Cash | 2,910 | 2,364 | 1,028 | 3,826 |
Free Cash Flow | -35,706 | -25,741 | -13,334 | -17,808 |
Cash | 155,568 | 165,332 | 269,723 | 98,679 |
Basic Shares | 60,205 | 59,936 | 10,308 | 21,950 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $14,018 | $6,627 | $0 | $0 |
Gross Profit | -8,907 | -631 | -755 | -755 |
EBITDA | -28,271 | -36,265 | -23,946 | -11,506 |
EBIT | -28,999 | -36,896 | -24,701 | -12,261 |
Net Income | -106,806 | -37,513 | -24,469 | -17,120 |
Net Change In Cash | 14,018 | 6,627 | 0 | 0 |
Cost of Revenue | -28,906 | 37,223 | ||
Free Cash Flow | -8,399 | -28,938 | -18,305 | -12,720 |
Cash | 98,679 | 20,323 | 49,229 | 39,766 |
Basic Shares | 19,843 | 12,126 | 11,538 | 10,111 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.78 |
2024-06-30 | -$0.49 |
2024-03-31 | -$2.51 |
2023-12-31 | -$4.22 |
